Facts and Figures
Very positive business development in 2019
In 2019, Greiner Bio-One employed a global workforce of 2,320 at 28 locations in 20 countries. The company achieved sales revenues of EUR 509 million, which represented growth of 8 percent over the preceding year (2018: EUR 473 million), and passed the EUR 500 million mark for the first time.
Therefore, in spite of a challenging market environment, the successful business trend of recent years was maintained. Moreover, extensive increases in capacity enabled the use of a range of fresh potential and new customers were also obtained. In particular, market shares were gained in the USA and Latin America and positive currency effects emanating from the exchange rates for the US dollar and Japanese yen generated additional momentum. The business result also benefited from the fall in raw material prices, which was particularly notable in the second half-year.
Greiner Bio-One looks to the coming year with confidence. New large-scale orders that come into effect in 2020, as well as continuous market growth, permit the next twelve months to be viewed with great optimism. The strong network of international production and sales locations, as well as the conclusion of current location and capacity enlargement will once again secure the supply of international customers with products of the highest quality.
2015 – 2019, figures are given in EUR millions
“Our focus is on a strong customer orientation and innovative, top quality product solutions.”
Rainer Perneker, CEO Greiner Bio-One International GmbH